ABEO - Abeona Therapeu Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 AAPL (-0.7%) VXX (-1.63%) SPY (0.15%) ROKU (4.45%) DGAZ (4.4%) UGAZ (-3.81%) TWTR (%) TVIX (-2.37%) TTD (-0.34%) AAOI (-3.88%) A (-0.52%) SNAP (-0.7%) SBUX (0.53%) RVLV (-3.1%) CSCO (-7.33%) CHK (-1.69%) ALB (0.56%) ACRE (0.4%) PINS (-2.97%) MELI (4.44%) LYFT (-3.19%) KOPN (1.62%) KO (0.42%) KIM (2.43%) JNPR (-1.11%)

ABEO - Abeona Therapeutics ...

$2.27 -0.06[-2.58%]

15 mins delayed data

People also watch : JNJ | MDGL | IRWD | AMAG | ENZN | EMIS

+Watchlist

2 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$2.33	Open	$2.43
Volume	200.8K	Market Cap	282.68M
Yield		Last Dividend

Day

52 Week

IMPORTANT INVESTOR ALERT: The Schall Law...	10:30 AM
LOS ANGELES, CA / ACCESSWIRE / November 14, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a clas...

SHAREHOLDER ALERT: Pawar Law Group Annou...	11/13/19
Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Abeona Therapeutics Inc. (ABEO)...

Bragar Eagel & Squire, P.C. Reminds Inve...	11/13/19
Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, reminds investors that class action lawsuits have been commenced on behalf ...

SHAREHOLDER ALERT: Pomerantz Law Firm Re...	11/13/19
NEW YORK, NY / ACCESSWIRE / November 13, 2019 / Pomerantz LLP announces that a class action lawsuit has been filed against Abeona Therapeutics Inc. ("...

Abeona Deadline Alert: Faruqi & Faruqi, ...	11/13/19
New York, New York--(Newsfile Corp. - November 13, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Abeona T...

INVESTOR ALERT - Abeona Therapeutics Inc...	11/13/19
NEW YORK, NY / ACCESSWIRE / November 13, 2019 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed again...

ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, A...	11/12/19
NEW YORK, Nov. 12, 2019 -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers o...

Abeona Therapeutics Reports Third Quarte...	11/12/19
Abeona Therapeutics Inc. (ABEO), a fully-integrated leader in gene and cell therapy, today announced third quarter 2019 financial results and business...

SHAREHOLDER ACTION NOTICE: The Schall La...	11/11/19
LOS ANGELES, CA / ACCESSWIRE / November 11, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a clas...

SHAREHOLDER ALERT - Abeona Therapeutics ...	11/11/19
NEW YORK, NY / ACCESSWIRE / November 11, 2019 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed again...

ABEONA DEADLINE ALERT: Faruqi & Faruqi, ...	11/11/19
New York, New York--(Newsfile Corp. - November 11, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Abeona T...

ANALYST RATINGS

2 analyst ratings (Last 6 months)

50.00 %

Strong Buy + Buy

Price Target (PT)

Buy rating	08/12/19
H.C. Wainwright initiates coverage with Buy rating and announces Price Target of $15.00

Hold rating	08/12/19
Cantor Fitzgerald downgrades from Overweight to Neutral rating and lowers Price Target from $29.00 to $2.00

EARNINGS

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

TRADERS TRACKING $ABEO

Service Name	Trader	% Success
Market Focus	Hao	60.00 %	Subscribe
Silent swinger	hasmat	38.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.